Viewing Study NCT05207904


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2025-12-28 @ 9:30 AM
Study NCT ID: NCT05207904
Status: UNKNOWN
Last Update Posted: 2022-01-26
First Post: 2021-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module